Showing results (141-150 of 201) with videos related to
Sort By:
Pageof 21
Blood|July 1, 1994
Evidence that tumor necrosis factor alpha (TNF)-induced activation of neutrophil respiratory burst on biologic surfaces is mediated by the p55 TNF receptorR Menegazzi, R Cramer, P Patriarca, et al.Acta Crystallographica. Section D, Biological Crystallography|February 15, 2001
Structure of hydroxynitrile lyase from Manihot esculenta in complex with substrates acetone and chloroacetone: implications for the mechanism of cyanogenesisH Lauble, S Förster, B Miehlich, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1977
The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytesK Pfizenmaier, H Jung, A Starzinski-Powitz, et al.The Journal of Experimental Medicine|April 1, 1976
Virus and trinitrophenol hapten-specific T-cell-mediated cytotoxicity against H-2 incompatible target cellsK Pfizenmaier, A Strazinski-Powitz, H Rodt, et al.The Journal of Biological Chemistry|February 25, 1994
PKCu is a novel, atypical member of the protein kinase C familyF J Johannes, J Prestle, S Eis, et al.Immunology|April 1, 1978
Primary in vitro sensitization of virus specific cytotoxic T lymphocytesH Jung, K Pfizenmaier, A Starzinski-Powitz, et al.Journal of Virology|February 1, 1988
Gamma interferon regulates long terminal repeat-controlled oncogene expression in transformed mouse fibroblasts at the level of mRNA transcriptionB Seliger, G Kruppa, R Schäfer, et al.Cell Death and Differentiation|March 30, 2001
TNF down-regulation of receptor tyrosine kinase-dependent mitogenic signal pathways as an important step in cytostasis induction and commitment to apoptosis of Kym-1 rhabdomyosarcoma cellsP Storz, H Döppler, J Horn-Müller, et al.European Journal of Immunology|September 1, 1976
Shared determinants between virus-infected and trinitrophenyl-conjugated H-2-identical target cells detected in cell-mediated lympholysisA Starzinski-Powitz, K Pfizenmaier, U Koszinowski, et al.Molecular Biotherapy|January 1, 1988
Phase I study of recombinant human tumor necrosis factor-alpha in patients with advanced malignanciesH H Bartsch, G A Nagel, R Mull, et al.Pageof 21